Hepatology

A study of 9,761 adults linked high allostatic load and unhealthy behaviours to increased all-cause and cardiovascular mortality among participants with MASLD.

CT radiomics and tumour heterogeneity predict β-catenin expression in hepatocellular carcinoma.

An AI model combining ctDNA methylation and clinical data achieved an AUC of 0.903 for detecting liver cancer in patients with hepatitis B.

Researchers identified blood protein markers that could differentiate primary biliary cholangitis from MASLD and healthy controls, highlighting the potential of proteomics to support earlier diagnosis and disease monitoring.

GLIM-defined malnutrition and cachexia were independently associated with shorter overall survival in patients with hepatocellular carcinoma treated with sorafenib.

A MASLD trial found liver fat reductions with initial advice, coaching and app support, without significant group differences.

A retrospective study of 611 patients found that a low CALLY index was independently associated with poorer disease-free survival and overall survival following hepatic resection for hepatocellular carcinoma.

Accelerated biological ageing predicts chronic liver disease.